This step-up approach allows your body to adjust, which helps minimize uncomfortable digestive changes and improves long-term tolerance
July 15 (Reuters) - Novo Nordisk said on Wednesday the European Commission approved its once-daily Wegovy pill for weight management in adults with obesity or who are overweight, making it the first oral GLP-1 weight-loss treatment cleared for use across the European Union
The injection can cause prostatic abscess and sepsis, although this is rare.25 Nevertheless, high fever and postprocedural pain should be carefully evaluated
Zepbound: SURMOUNT-1 The average starting weight for study participants in SURMOUNT-1 was 105 kg (231 lb)
Both formulations deliver the same regenerative results
Other important safety considerations include injection site reactions, increased heart rate (a class effect, though potentially more pronounced with liraglutide), and risk of pancreatitis (which requires immediate discontinuation if suspected)